139 results
Page 3 of 7
S-3ASR
l6ao1jdp
2 Feb 21
Automatic shelf registration
8:11am
8-K
txw8rtu864
11 Jan 21
Amicus Therapeutics Reports Preliminary 2020 Revenue and Provides 2021 Outlook
7:00am
8-K
EX-99.1
2b3p7x4ge wzbhw
11 Jan 21
Amicus Therapeutics Reports Preliminary 2020 Revenue and Provides 2021 Outlook
7:00am
8-K
EX-99.2
zc8v6mi 3k3iqwkj
11 Jan 21
Amicus Therapeutics Reports Preliminary 2020 Revenue and Provides 2021 Outlook
7:00am
8-K
EX-99.1
98etl
17 Jul 20
Amicus Therapeutics Secures $400 Million Non-Dilutive Debt Financing
7:33am
8-K
EX-99.1
q1js4k2p
7 May 20
Amicus Therapeutics Announces First Quarter 2020 Financial Results and Corporate Updates
7:00am
8-K
EX-99.1
hc74e87k84 tie
7 Feb 20
Amicus Therapeutics Announces Presentations and Posters at 16th Annual WORLDSymposiumâ„¢ 2020
7:01am
8-K
EX-99.1
3h42c090zlv7nk
13 Jan 20
Amicus Therapeutics Provides Full-Year 2020 Strategic Outlook and Financial Guidance
7:00am
8-K
EX-99.2
4p5v377c sgj
13 Jan 20
Amicus Therapeutics Provides Full-Year 2020 Strategic Outlook and Financial Guidance
7:00am
8-K
oaus011qd3wrw wz3
13 Jan 20
Amicus Therapeutics Provides Full-Year 2020 Strategic Outlook and Financial Guidance
7:00am
8-K
EX-99.1
7vnk5vkjd sk8
9 Jan 20
Amicus Therapeutics Announces Preliminary 2019 Galafold Revenue - Exceeding Upper End of Prior Guidance
7:03am
8-K
EX-99.1
26ih5uexwkc yr9q87
7 Jan 20
Amicus Therapeutics Provides Updates on Clinical, Regulatory and Manufacturing Advancements for AT-GAA for Pompe Disease
7:01am